Plantar Fasciitis Treatment: Influence of the Possible Presence of Subchondral Bone Edema
NCT ID: NCT05925777
Last Updated: 2025-05-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
24 participants
INTERVENTIONAL
2023-08-01
2025-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Laser therapy is indicated for plantar fasciitis, in particular for its biological anti-inflammatory, anti-edema and reparative effects on the plantar fascia; to date, the potential effects also on the underlying bone edema component, when present, which aggravates and self-maintains the ongoing pathology are not known.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endoscopic Debridement of Chronic Plantar Fasciitis
NCT06535724
Heavy-slow Resistance Training and Ultrasound-guided Corticosteroid Injection in Plantar Fasciopathy
NCT03535896
Early Intervention With Therapeutic Exercise in Plantar Fasciopathy
NCT06394336
Effectiveness of Strengthening Exercise Program Compare With Foot Orthoses in Patients With Plantar Heel Pain
NCT05059054
Exercise Versus Corticosteroid Randomized Clinical Trial for Plantar Fasciitis
NCT01297686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
The protocol provides for the administration of 10 polymodal high energy laser therapy sessions, to be carried out every other day. The THEAL device (Mectronic, Bergamo) allows to deliver 4 wavelengths (650 nm, 810 nm, 980 nm and 1064 nm), with continuous and pulsed mode, with power up to 20 W.
Patients will perform stretching exercise like those of the control group.
THEAL (Mectronic, Bergamo)
laser therapy high intensity
Control group
Patients will perform four daily stretching exercises (three sets of 30 seconds), for 6 weeks.
1. Hamstring and ankle plantar flexor stretch (straight leg raise in supine position)
2. self-stretching of the surae muscles: the patient bends forward in a standing position with the affected foot farthest from the wall, keeping the heel on the floor; 3. the soleus muscle is exercised with the knee flexed and the gastrocnemius muscle with the knee extended
4\. Plantar fascia self-stretch: In a seated position, the patient crosses the affected foot over the contralateral thigh and passively extends the metatarsophalangeal joints .
In the first session, the volunteers will be trained on how to perform the exercises correctly and will be monitored once a week.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
THEAL (Mectronic, Bergamo)
laser therapy high intensity
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Pain on palpation of the medial calcaneal tubercle or proximal plantar fascia,
3. plantar fascia thickness of 4.0 mm or greater.
Exclusion Criteria
2. history of systemic disease
3. pregnancy
4. Previous surgery on the lower limbs
5. diagnosis of fibromyalgia, neurological disease, Achilles tendinopathy, metatarsalgia, acute ankle sprain, tarsal tunnel syndrome, or heel joint syndrome
6. body mass index (BMI) greater than 35 kg/m2
7. wounds, infections in the treatment area
8. altered sensation in the treatment area
9. skin pigmentation alterations in the area to be treated (tattoo, dyschromia)
10. metal implants in the treatment area
11. History of oral or injected corticosteroid therapy within the past six weeks
12. Diagnosis of neurological heel pain (radiculopathy)
13. diagnosis of systemic inflammatory arthritis (rheumatoid arthritis, etc.)
14. other acute pathologies (febrile fever, cold, etc.) requiring treatment
15. other painful conditions requiring painkillers (toothache, back pain, etc.)
16. neoplasms
17. cardiac pacemaker or other device.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Angela Notarnicola
Bari, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
DiGiovanni BF, Nawoczenski DA, Lintal ME, Moore EA, Murray JC, Wilding GE, Baumhauer JF. Tissue-specific plantar fascia-stretching exercise enhances outcomes in patients with chronic heel pain. A prospective, randomized study. J Bone Joint Surg Am. 2003 Jul;85(7):1270-7. doi: 10.2106/00004623-200307000-00013.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THEAL-fasc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.